SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as the community debates its outlook ahead of earnings, with the stock drawing heavy interest from traders tracking its Pro segment performance and macro correlations to interest rates. Investors are actively weighing the impact of cooling consumer demand against potential upside from technical oversold signals and expected stability in dividend-paying assets.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global Holdings is trending as investors react to a strong quarterly earnings report that featured a revenue beat and raised guidance, fueling community optimism around its AI-driven growth. Despite the positive results, active discussion reflects frustration with ongoing share price volatility and short-term selling pressure, while long-term supporters remain focused on the company's expanding enterprise partnerships and AI-powered platform adoption.

Energy Vault Holdings, Inc. engages in the provision of energy storage solutions. The company was founded in September 2020 and is headquartered in Westlake Village, CA.

Energy Vault Holdings Inc

Energy Vault is currently trending as investors focus on recent strategic partnership announcements, including a major development agreement in South Africa and expansion into AI-dedicated infrastructure. While the community is actively debating the company's long-term potential versus concerns regarding dilution and volatility, sentiment remains split between bullish technical setups and frustration over recent market performance.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending following a significant merger agreement with NextEra Energy, creating a global utility powerhouse designed to meet surging power demand from AI data centers. The community is actively debating the deal's regulatory feasibility, the potential impact on customer electricity rates, and whether the all-stock transaction represents a bargain or an overextension.

Amer Sports, Inc. engages in manufacturing, marketing, and selling sports equipment, apparel, and footwear. It operates through the following segments: Technical Apparel, Outdoor Performance, and Ball and Racquet Sports. The Technical Apparel segment refers to outdoor apparel, footwear, and accessories. It includes the Arc’teryx and Peak Performance brands. The Outdoor Performance segment focuses on outdoor apparel, footwear, accessories, and winter sports equipment. It includes the Salomon, Atomic, Armada, and ENVE brands. The Ball and Racquet Sports segment relates to sports equipment, apparel, and accessories. It includes the Wilson, Louisville Slugger, DeMarini, EvoShield, Atec, and Luxilon brands. The company was founded on January 03, 2020 and is headquartered in Helsinki, Finland.

Amer Sports Inc.

Amer Sports is trending as investors react to a strong quarterly earnings report that featured revenue growth and an upward revision to full-year guidance. The community is actively discussing the company's impressive profit margins, its portfolio of premium outdoor brands like Arc'teryx, and contrasting its performance with other consumer discretionary peers.

MakeMyTrip Ltd. engages in the provision of travel services. It offers air ticketing, hotels and packages, rail tickets, bus tickets, car hire, experiences and ancillary travel requirements such as foreign currency exchange services, visa processing, facilitating access to travel, and other insurance products. The company was founded by Deep Kalra and Rajesh Magow on April 28, 2000 and is headquartered in Gurgaon, India.

MakeMyTrip Ltd

MakeMyTrip is trending as investors monitor the company's strong category leadership and massive growth potential within India's expanding travel market, often drawing comparisons to other dominant global online travel agencies. While the stock has seen notable momentum and breakout patterns following solid earnings results, the community remains actively divided between those highlighting long-term structural tailwinds and those cautious of potential overvaluation or broader macroeconomic headwinds.

Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. The Real Estate segment includes management of opportunistic real estate funds, Core+ real estate funds, high-yield real estate debt funds, and liquid real estate debt funds. The Private Equity segment consists of management of flagship corporate private equity funds, sector and geographically focused corporate private equity funds, core private equity funds, an opportunistic investment platform, a secondary fund of funds business, infrastructure-focused funds, a life sciences investment platform, a growth equity investment platform, a multi-asset investment program for eligible high net worth investors and a capital markets services business. The Credit and Insurance segment refers to Blackstone Credit, which is organized into two overarching strategies: private credit which includes mezzanine direct lending funds, private placement strategies, stressed and distressed strategies and energy strategies, and liquid credit which consists of CLOs, closed-ended funds, open ended funds and separately managed accounts. In addition, the segment includes an insurer-focused platform, an asset-based finance platform, and publicly traded master limited partnership investment platform. The Hedge Fund Solutions segment focuses on Blackstone Alternative Asset Management, which manages a broad range of commingled and customized hedge fund of fund solutions. It also includes a GP Stakes business and investment platforms that invest directly, as well as investment platforms that seed new hedge fund businesses and create alternative solutions through daily liquidity products. The company was founded by Stephen Allen Schwarzman in 1985 and is headquartered in New York, NY.

Blackstone Inc

Blackstone is trending as investors weigh its aggressive expansion into AI infrastructure and data centers against regulatory headwinds, specifically recent political proposals aimed at limiting institutional investment in residential real estate. While the stock faces near-term volatility from these policy risks, market participants remain focused on the company's massive dry powder and its pivotal role in financing the next wave of global AI compute capacity.

River is building a chain-abstraction stablecoin system that enables cross-chain collateral, yield, and liquidity—all without bridging.   Powered by the omni-CDP stablecoin satUSD, users can earn, leverage, and scale across different ecosystems natively.   River features the first omni-CDP module that allows users to collateralize assets on Chain A and mint stablecoin satUSD on Chain B—without bridging the assets.

River

River is experiencing high volatility and intense community debate as traders speculate on potential exchange listings, supply constraints, and its unique role in stablecoin infrastructure. Participants are actively monitoring price action for signs of a short squeeze or further downside, while frequently comparing its market structure to other recent high-momentum crypto assets.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is drawing intense community focus following a combination of significant insider buying from company leadership and the pending acquisition of Distributed Technologies Research, which has sparked speculation about the firm's pivot toward stablecoin and agentic payment infrastructure. Despite this, investors remain divided, with long-term shareholders expressing skepticism over past performance and dilution risks while some traders bet on a potential squeeze and favorable regulatory tailwinds.

Enhanced Group, Inc. is an elite sports competition and performance products company committed to providing athletes and consumers with products that support health, performance, and recovery. The company offers a portfolio of products and experiences that combine athletic competition, scientific innovation, and consumer engagement. The company is headquartered in New York, NY.

Enhanced Group Inc. - Ordinary Shares - Class A

Enhanced Group Inc

Enhanced Group is capturing investor attention following its recent NYSE listing and a series of strategic partnerships, including a major streaming deal with Roku and a collaboration with Zoop to support the upcoming inaugural Enhanced Games. Community discourse is heavily focused on the company's hybrid model that combines elite sports entertainment with a telehealth and longevity platform, leading to active debate regarding the sustainability of its business model and potential for long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is WORK Medical Technology Stock Falling Friday?

WORK Medical (WOK) stock drops 49% to $0.66 on Friday as investors take profits following historic weekly volatility.read more...

<ul class="summary-bullets"><li>On Monday, Work Medical announced a partnership with Shanghai Novabioplus Biotechnology to develop AI-powered healthcare and drug discovery systems.</li><li>The deal includes AI-based projects involving protein design, antibody optimization, enzyme engineering and peptide development.</li><li>Investors also focused on the company’s new “BioToken” concept, which involves creating blockchain-based digital biological assets.</li></ul>Shares of Work Medical Technology Group (WOK) skyrocketed nearly 300% so far this week after the China-based medical device company announced an AI biotech partnership and expanded its push into blockchain-based healthcare infrastructure.<a href="https://stocktwits.com/symbol/WOK">WOK stock</a> surged more than 200% on Monday after the partnership announcement and gained another 70% on Tuesday. The rally continued in Tuesday’s after-hours session, with shares jumping another 70% to become the session’s top after-hours gainer.&nbsp;<h2 class="st-heading-2">WOK AI Healthcare Deal Fuels Rally</h2>The rally accelerated after Work Medical said on Monday that it had struck a deal with Shanghai Novabioplus Biotechnology to develop AI-based healthcare and drug discovery systems using biological datasets. The two companies plan to combine Work Medical’s healthcare AI tech with Novabioplus’ protein research databases and lab platforms to build advanced medical models and improve biotech research and development.According to the company, the partnership strengthens its broader “Healthcare + Web3 + AI” strategy, particularly in biopharmaceutical research. The collaboration includes four major AI-focused projects involving protein structure design, antibody optimization, enzyme engineering and peptide development. The companies said the goal is to use AI to analyze complex biological data, improve molecular design and speed up parts of the drug discovery process.Work Medical said that the partnership could also support the development of AI-assisted protein and antibody therapies by combining its AI algorithms with Novabioplus’ protein datasets and biological research infrastructure.<h2 class="st-heading-2">Work Medical’s ‘BioToken’ Push&nbsp;</h2>WOK shares drew particular attention after the company introduced the concept of “BioTokens,” blockchain-based digital assets tied to biological datasets and protein therapeutics. Work Medical said that the deal with Novabioplus aims to generate AI-driven multimodal biological data “BioTokens” by integrating protein sequences, functional biological data and laboratory datasets into AI models for protein molecular design.The company said the platform is expected to optimize protein structures and improve biological functions, while generating digital biological assets with “assetization potential.” According to Work Medical, the BioToken model could transform biopharmaceutical research outputs into “verifiable and measurable digital assets.”<h2 class="st-heading-2">WOK Deepens Web3 Strategy</h2>The latest AI-biotech announcement comes after several blockchain and tokenization initiatives unveiled by the company this year. Earlier this month, Work Medical said it had been formally awarded a Council Member certificate as a Vice President Unit of the Hong Kong Web3.0 Standardization Association, an organization focused on Web3 standardization research.The announcement came after Hong Kong implemented its stablecoin regulatory framework in August 2025, which Work Medical said accelerated interest among Chinese-listed companies exploring blockchain integration and asset tokenization. Work Medical said it has been advancing a broader strategy involving healthcare real-world asset tokenization, AI Agent-to-Agent payments and stablecoin-enabled cross-border settlement systems to create digital infrastructure for medical assets.The company added that it contributed to an Asset Tokenization Whitepaper released during the Web3.0 Standardization and Globalization Summit in Hong Kong in April. According to Work Medical, the whitepaper established foundational standards for industrial asset digitization and compliance frameworks for healthcare-related digital assets.Work Medical said the company is transitioning from a traditional medical consumables supplier into a builder of “next-generation medical infrastructure powered by AI and blockchain.”<h2 class="st-heading-2">AI Blood Analyzer Added Early Buzz</h2>Investor interest in Work Medical’s AI ambitions had already started building late last year after the commercialization rollout of its AI-Automated Blood Cell Morphology Analyzer in China. In December, the company said that its unit, Hunan Saitumofei Medical Treatment Technology, had entered into a one-year exclusive distribution agreement with Shanghai Benke Medical Technology to distribute the analyzer throughout East China in 2026.The agreement covered Jiangsu Province, Shanghai Municipality and Zhejiang Province and included a minimum annual sales target of 10 million yuan ($1.5 million). The analyzer received Class II medical device manufacturing approval from Chinese regulators in November and uses AI-driven automation and high-resolution digital imaging technology to identify and classify blood cells.According to the company, the system can process up to 150 samples at a time, identify 17 different types of white blood cells and analyze a blood smear in about three minutes on average. Work Medical said the analyzer can store over 350,000 high-definition blood cell images and uses AI-based image analysis tech to make results easier for medical professionals to interpret, while helping reduce potential diagnostic risks.<h2 class="st-heading-2">How Do Retail Traders Feel About WOK?</h2>On Stocktwits, retail sentiment for WOK was ‘extremely bullish’ amid a massive 34,275% surge in message volumes over the past three months. The stock’s retail watcher base has also jumped 30% in a week.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/wok_ss_png_0a50f4ed37.webp" alt="wok ss.png" width="972" height="149"><figcaption>WOK sentiment and message volume as of May 12 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Bleedner/message/653155109">outlined</a> their trading strategy and said, “Out at $9, will look for re-entry tomorrow, but this thing has been wildddd. Up 4,500% since lows of yesterday.”<stembedurl>https://stocktwits.com/Bleedner/message/653155109</stembedurl>Another user said WOK stock could “just run the rest of the week” and compared the rally to an earlier surge in cannabis company AKAN.&nbsp;<stembedurl>https://stocktwits.com/JdNews/message/653155574</stembedurl>WOK stock crashed 99.9% over the past year, but surged 206% since January.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sls-stock-pops-big-after-hours-on-imminent-leukemia-trial-data-readout-optimism/cZXXrpWRe0T">SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism&nbsp;</a>

WOK stock crashed 99.9% over the past year, but surged 206% since January. (Photo credit: Getty Images)

Why Did WOK Stock Skyrocket Nearly 300% In Just 2 Days?

The company is building infrastructure involving healthcare asset tokenization, AI Agent-to-Agent payments, and stablecoin-enabled settlement for medical assets.

Equity

What's Going On With WORK Medical Technology Group Stock Today?

Shares of WORK Medical are rising Monday after the company received manufacturing approval for one of its AI-powered products.read more...

<ul class="summary-bullets"><li>The system combines advanced imaging with AI software to analyze blood smears, conduct white blood cell counts, and assess red blood cells and platelets.</li><li>The company expects to begin manufacturing the analyzer in the first half of 2026.</li><li>Work Medical Technology had announced a 1-for-100 reverse stock split last week to comply with Nasdaq’s minimum price rule.</li></ul>Work Medical Technology Group (WOK) shares jumped more than 50% on Monday, before paring some of the gains, after the company secured Chinese regulatory approval to manufacture an AI-powered blood analysis device. At the same time, the stock also began trading on a reverse split basis.Work’s China-based subsidiary has secured regulatory approval from the Hunan Provincial Medical Products Administration to manufacture a Class II AI-powered medical device, called the AI-Automated Human Blood Cell Morphology Analyzer.The system combines advanced imaging hardware with AI software to analyze blood smears and perform white blood cell differential counts, while also assessing red blood cells and platelets. It will use deep-learning algorithms and a fully automated workflow to improve accuracy and consistency in laboratory testing. Work Medical expects to begin manufacturing the analyzer in the first half of 2026.Work’s CEO and chairman, Shuang Wu, expects that, with ongoing AI upgrades and deeper workflow integration, the device will become standard equipment across hospital hematology and oncology departments as well as primary-care labs.“We are optimistic about this product line’s growth and its revenue potential for the company,” Shuang Wu said.<h2 class="st-heading-2">1-For-100 Reverse Split</h2>Last week, <a href="https://stocktwits.com/symbol/WOK">Work Medical</a> said it would implement a 1-for-100 reverse stock split of its ordinary shares, effective on December 29. This resulted in every 100 shares of the company’s outstanding Class A and Class B ordinary shares being combined into one ordinary share. The move is aimed at maintaining compliance with Nasdaq’s minimum bid price requirement of $1.00.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits surrounding the stock shifted to ‘bullish’ from ‘bearish’ a day earlier.One user expects support at $3.87.<stembedurl>https://stocktwits.com/Zackpedia/message/640305180</stembedurl>Another user sees strong upside.<stembedurl>https://stocktwits.com/trading_momentum_x/message/640304021</stembedurl>Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/silver-pullback-from-80-drives-hl-ag-paas-stock-lower/cL75u1sRExP">Silver’s $80 Breach Sparks Strong Pullback, Miners Feel The Heat: HL, AG, PAAS Stocks Drop Premarket</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

Why Did WOK Stock Surge Over 50% Today?

The company’s unit secured Chinese approval for an AI-powered blood analysis device, and the stock also began trading on a reverse-split basis from Monday.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

WOK
Work Medical Technology Group Ltd

Feed

News

Sentiment

Fundamentals

Info

Historical Earnings

Latest WOK News

WOKWork Medical Technology Group Ltd